Selected research
Industry Research
Liquid-filled Hard Capsules (LFHCs) Industry Research Report 2026
Market perspective
The global Liquid-filled Hard Capsules (LFHCs) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Liquid-filled Hard Capsules (LFHCs) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Liquid-filled Hard Capsules (LFHCs) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Liquid-filled Hard Capsules (LFHCs) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Liquid-filled Hard Capsules (LFHCs) include Bright Pharmacaps Inc., CapsCanada, Erawat Pharma, Farmacapsulas, Ion Labs, Lonza (Capsugel), Sanupharm, Suheung and Jiangsu Lefan Capsule, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Liquid-filled Hard Capsules (LFHCs) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Liquid-filled Hard Capsules (LFHCs) Market by Company
Bright Pharmacaps Inc.
CapsCanada
Erawat Pharma
Farmacapsulas
Ion Labs
Lonza (Capsugel)
Sanupharm
Suheung
Jiangsu Lefan Capsule
JCCAPS
Shanghai Key Biotechnology
Liquid-filled Hard Capsules (LFHCs) Segment by Type
Gelatin
Vegetarian
Liquid-filled Hard Capsules (LFHCs) Segment by Application
Pharmaceutical
Health Supplements
Others
Liquid-filled Hard Capsules (LFHCs) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liquid-filled Hard Capsules (LFHCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liquid-filled Hard Capsules (LFHCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liquid-filled Hard Capsules (LFHCs).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Liquid-filled Hard Capsules (LFHCs) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Liquid-filled Hard Capsules (LFHCs) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Liquid-filled Hard Capsules (LFHCs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gelatin
- Vegetarian
Applications
- Pharmaceutical
- Health Supplements
- Others
Companies covered
- Bright Pharmacaps Inc.
- CapsCanada
- Erawat Pharma
- Farmacapsulas
- Ion Labs
- Lonza (Capsugel)
- Sanupharm
- Suheung
- Jiangsu Lefan Capsule
- JCCAPS
- Shanghai Key Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Liquid-filled Hard Capsules (LFHCs) Market Size (2021-2032)
- 2.2.2 Global Liquid-filled Hard Capsules (LFHCs) Sales (2021-2032)
- 2.2.3 Global Liquid-filled Hard Capsules (LFHCs) Market Average Price (2021-2032)
- 2.3 Liquid-filled Hard Capsules (LFHCs) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gelatin
- 2.3.3 Vegetarian
- 2.4 Liquid-filled Hard Capsules (LFHCs) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical
- 2.4.3 Health Supplements
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Liquid-filled Hard Capsules (LFHCs) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Liquid-filled Hard Capsules (LFHCs) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Liquid-filled Hard Capsules (LFHCs) Revenue of Manufacturers (2021-2026)
- 3.4 Global Liquid-filled Hard Capsules (LFHCs) Average Price by Manufacturers (2021-2026)
- 3.5 Global Liquid-filled Hard Capsules (LFHCs) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Liquid-filled Hard Capsules (LFHCs), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Liquid-filled Hard Capsules (LFHCs), Product Type & Application
- 3.8 Global Manufacturers of Liquid-filled Hard Capsules (LFHCs), Established Date
- 3.9 Global Liquid-filled Hard Capsules (LFHCs) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bright Pharmacaps Inc.
- 4.1.1 Bright Pharmacaps Inc. Company Information
- 4.1.2 Bright Pharmacaps Inc. Business Overview
- 4.1.3 Bright Pharmacaps Inc. Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bright Pharmacaps Inc. Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.1.5 Bright Pharmacaps Inc. Recent Developments
- 4.2 CapsCanada
- 4.2.1 CapsCanada Company Information
- 4.2.2 CapsCanada Business Overview
- 4.2.3 CapsCanada Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CapsCanada Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.2.5 CapsCanada Recent Developments
- 4.3 Erawat Pharma
- 4.3.1 Erawat Pharma Company Information
- 4.3.2 Erawat Pharma Business Overview
- 4.3.3 Erawat Pharma Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Erawat Pharma Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.3.5 Erawat Pharma Recent Developments
- 4.4 Farmacapsulas
- 4.4.1 Farmacapsulas Company Information
- 4.4.2 Farmacapsulas Business Overview
- 4.4.3 Farmacapsulas Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Farmacapsulas Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.4.5 Farmacapsulas Recent Developments
- 4.5 Ion Labs
- 4.5.1 Ion Labs Company Information
- 4.5.2 Ion Labs Business Overview
- 4.5.3 Ion Labs Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ion Labs Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.5.5 Ion Labs Recent Developments
- 4.6 Lonza (Capsugel)
- 4.6.1 Lonza (Capsugel) Company Information
- 4.6.2 Lonza (Capsugel) Business Overview
- 4.6.3 Lonza (Capsugel) Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lonza (Capsugel) Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.6.5 Lonza (Capsugel) Recent Developments
- 4.7 Sanupharm
- 4.7.1 Sanupharm Company Information
- 4.7.2 Sanupharm Business Overview
- 4.7.3 Sanupharm Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanupharm Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.7.5 Sanupharm Recent Developments
- 4.8 Suheung
- 4.8.1 Suheung Company Information
- 4.8.2 Suheung Business Overview
- 4.8.3 Suheung Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Suheung Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.8.5 Suheung Recent Developments
- 4.9 Jiangsu Lefan Capsule
- 4.9.1 Jiangsu Lefan Capsule Company Information
- 4.9.2 Jiangsu Lefan Capsule Business Overview
- 4.9.3 Jiangsu Lefan Capsule Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jiangsu Lefan Capsule Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.9.5 Jiangsu Lefan Capsule Recent Developments
- 4.10 JCCAPS
- 4.10.1 JCCAPS Company Information
- 4.10.2 JCCAPS Business Overview
- 4.10.3 JCCAPS Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 JCCAPS Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.10.5 JCCAPS Recent Developments
- 4.11 Shanghai Key Biotechnology
- 4.11.1 Shanghai Key Biotechnology Company Information
- 4.11.2 Shanghai Key Biotechnology Business Overview
- 4.11.3 Shanghai Key Biotechnology Liquid-filled Hard Capsules (LFHCs) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shanghai Key Biotechnology Liquid-filled Hard Capsules (LFHCs) Product Portfolio
- 4.11.5 Shanghai Key Biotechnology Recent Developments
5 Global Liquid-filled Hard Capsules (LFHCs) Market Scenario by Region
- 5.1 Global Liquid-filled Hard Capsules (LFHCs) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Liquid-filled Hard Capsules (LFHCs) Sales by Region: 2021-2032
- 5.2.1 Global Liquid-filled Hard Capsules (LFHCs) Sales by Region: 2021-2026
- 5.2.2 Global Liquid-filled Hard Capsules (LFHCs) Sales by Region: 2027-2032
- 5.3 Global Liquid-filled Hard Capsules (LFHCs) Revenue by Region: 2021-2032
- 5.3.1 Global Liquid-filled Hard Capsules (LFHCs) Revenue by Region: 2021-2026
- 5.3.2 Global Liquid-filled Hard Capsules (LFHCs) Revenue by Region: 2027-2032
- 5.4 North America Liquid-filled Hard Capsules (LFHCs) Market Facts & Figures by Country
- 5.4.1 North America Liquid-filled Hard Capsules (LFHCs) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Liquid-filled Hard Capsules (LFHCs) Sales by Country (2021-2032)
- 5.4.3 North America Liquid-filled Hard Capsules (LFHCs) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Liquid-filled Hard Capsules (LFHCs) Market Facts & Figures by Country
- 5.5.1 Europe Liquid-filled Hard Capsules (LFHCs) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Liquid-filled Hard Capsules (LFHCs) Sales by Country (2021-2032)
- 5.5.3 Europe Liquid-filled Hard Capsules (LFHCs) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Liquid-filled Hard Capsules (LFHCs) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Liquid-filled Hard Capsules (LFHCs) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Liquid-filled Hard Capsules (LFHCs) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Liquid-filled Hard Capsules (LFHCs) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Liquid-filled Hard Capsules (LFHCs) Market Facts & Figures by Country
- 5.7.1 South America Liquid-filled Hard Capsules (LFHCs) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Liquid-filled Hard Capsules (LFHCs) Sales by Country (2021-2032)
- 5.7.3 South America Liquid-filled Hard Capsules (LFHCs) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Liquid-filled Hard Capsules (LFHCs) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Liquid-filled Hard Capsules (LFHCs) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Liquid-filled Hard Capsules (LFHCs) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Liquid-filled Hard Capsules (LFHCs) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Liquid-filled Hard Capsules (LFHCs) Sales by Type (2021-2032)
- 6.1.1 Global Liquid-filled Hard Capsules (LFHCs) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Liquid-filled Hard Capsules (LFHCs) Sales Market Share by Type (2021-2032)
- 6.2 Global Liquid-filled Hard Capsules (LFHCs) Revenue by Type (2021-2032)
- 6.2.1 Global Liquid-filled Hard Capsules (LFHCs) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Liquid-filled Hard Capsules (LFHCs) Revenue Market Share by Type (2021-2032)
- 6.3 Global Liquid-filled Hard Capsules (LFHCs) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Liquid-filled Hard Capsules (LFHCs) Sales by Application (2021-2032)
- 7.1.1 Global Liquid-filled Hard Capsules (LFHCs) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Liquid-filled Hard Capsules (LFHCs) Sales Market Share by Application (2021-2032)
- 7.2 Global Liquid-filled Hard Capsules (LFHCs) Revenue by Application (2021-2032)
- 7.2.1 Global Liquid-filled Hard Capsules (LFHCs) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Liquid-filled Hard Capsules (LFHCs) Revenue Market Share by Application (2021-2032)
- 7.3 Global Liquid-filled Hard Capsules (LFHCs) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Liquid-filled Hard Capsules (LFHCs) Value Chain Analysis
- 8.1.1 Liquid-filled Hard Capsules (LFHCs) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Liquid-filled Hard Capsules (LFHCs) Production Mode & Process
- 8.2 Liquid-filled Hard Capsules (LFHCs) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Liquid-filled Hard Capsules (LFHCs) Distributors
- 8.2.3 Liquid-filled Hard Capsules (LFHCs) Customers
9 Global Liquid-filled Hard Capsules (LFHCs) Analyzing Market Dynamics
- 9.1 Liquid-filled Hard Capsules (LFHCs) Industry Trends
- 9.2 Liquid-filled Hard Capsules (LFHCs) Industry Drivers
- 9.3 Liquid-filled Hard Capsules (LFHCs) Industry Opportunities and Challenges
- 9.4 Liquid-filled Hard Capsules (LFHCs) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst